Stryker Corporation (SYK) : Clifford Swan Investment Counsel reduced its stake in Stryker Corporation by 4.02% during the most recent quarter end. The investment management company now holds a total of 175,840 shares of Stryker Corporation which is valued at $20,321,829 after selling 7,361 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Stryker Corporation makes up approximately 1.37% of Clifford Swan Investment Counsel’s portfolio.
Other Hedge Funds, Including , Blackrock Institutional Trust Company N.a. reduced its stake in SYK by selling 143,993 shares or 1.66% in the most recent quarter. The Hedge Fund company now holds 8,525,450 shares of SYK which is valued at $985,286,257. Stryker Corporation makes up approx 0.15% of Blackrock Institutional Trust Company N.a.’s portfolio.Signature Estate Investment Advisors boosted its stake in SYK in the latest quarter, The investment management firm added 499 additional shares and now holds a total of 1,628 shares of Stryker Corporation which is valued at $186,927. Stryker Corporation makes up approx 0.03% of Signature Estate Investment Advisors’s portfolio.Twin Capital Management Inc reduced its stake in SYK by selling 340 shares or 2.9% in the most recent quarter. The Hedge Fund company now holds 11,400 shares of SYK which is valued at $1,317,042. Stryker Corporation makes up approx 0.10% of Twin Capital Management Inc’s portfolio.Wedbush Securities Inc reduced its stake in SYK by selling 203 shares or 3.53% in the most recent quarter. The Hedge Fund company now holds 5,548 shares of SYK which is valued at $637,021. Stryker Corporation makes up approx 0.10% of Wedbush Securities Inc’s portfolio. Chicago Equity Partners sold out all of its stake in SYK during the most recent quarter. The investment firm sold 2,485 shares of SYK which is valued $288,956.
Stryker Corporation opened for trading at $113.32 and hit $113.8 on the upside on Friday, eventually ending the session at $113.77, with a gain of 0.02% or 0.02 points. The heightened volatility saw the trading volume jump to 8,81,320 shares. Company has a market cap of $42,584 M.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.